Zobrazeno 1 - 10
of 556
pro vyhledávání: '"Alvaro Moreno"'
Autor:
Xiaojia Tang, Kevin J. Thompson, Krishna R. Kalari, Jason P. Sinnwell, Vera J. Suman, Peter T. Vedell, Sarah A. McLaughlin, Donald W. Northfelt, Alvaro Moreno Aspitia, Richard J. Gray, Jodi M. Carter, Richard Weinshilboum, Liewei Wang, Judy C. Boughey, Matthew P. Goetz
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-18 (2023)
Abstract Background Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Patients with TNBC are primarily treated with neoadjuvant chemotherapy (NAC). The response to NAC is prognostic, with reductions in overall surviva
Externí odkaz:
https://doaj.org/article/3af3f74d177a4754a631cf8c8eef5d57
Autor:
Jennifer Berrian, Ying Liu, Nkiruka Ezenwajiaku, Alvaro Moreno‐Aspitia, Sara J. Holton, Adetunji T. Toriola, Graham A. Colditz, Ashley J. Housten, Lannis Hall, Mark A. Fiala, Foluso O. Ademuyiwa
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7381-7388 (2023)
Abstract Purpose To determine if the COVID‐19 pandemic has further exacerbated racial disparities in late‐stage presentation of breast, colorectal, lung, and prostate cancers. Methods We conducted a registry‐based retrospective study of patient
Externí odkaz:
https://doaj.org/article/1d0cb9ad009d4c1a902d1ad3c26a0f94
Autor:
Foluso O. Ademuyiwa, Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, E. Claire Dees, Cesar A. Santa-Maria, Roisin M. Connolly, Jeremy Force, Alvaro Moreno-Aspitia, John M. Herndon, Madelyn Carmody, Sherri R. Davies, Sarah Larson, Kathleen L. Pfaff, Stephanie M. Jones, Jason L. Weirather, Anita Giobbie-Hurder, Scott J. Rodig, Zheng Liu, Ian S. Hagemann, Elad Sharon, William E. Gillanders
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Atezolizumab with chemotherapy has shown improved progression-free and overall survival in patients with metastatic PD-L1 positive triple negative breast cancer (TNBC). Atezolizumab with anthracycline- and taxane-based neoadjuvant chemothera
Externí odkaz:
https://doaj.org/article/d2b06f8f41a040519a09fe040f35b01e
Autor:
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer, Sarra El-Abed, Yingbo Wang, Malou Vicente, Saranya Chumsri, Judith Bliss, Judith Kroep, Marco Colleoni, Fausto Petrelli, Lucia Del Mastro, Alvaro Moreno-Aspitia, Martine Piccart, Marianne Paesmans, Evandro de Azambuja, Matteo Lambertini
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract The prognostic performance of PREDICT in patients with HER2-positive early breast cancer (EBC) treated in the modern era with effective chemotherapy and anti-HER2 targeted therapies is unclear. Therefore, we investigated its prognostic perfo
Externí odkaz:
https://doaj.org/article/26e9c2c289cb4f0e805a3be45e4ff06d
Autor:
Saranya Chumsri, Zhuo Li, Daniel J. Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner, Heather Ann Brauer, Sarah Warren, Patrick Danaher, Gerardo Colon-Otero, Ann H. Partridge, Lisa A. Carey, Florentine Hilbers, Veerle Van Dooren, Eileen Holmes, Serena Di Cosimo, Olena Werner, Jens Bodo Huober, Amylou C. Dueck, Christos Sotiriou, Cristina Saura, Alvaro Moreno-Aspitia, Keith L. Knutson, Edith A. Perez, E. Aubrey Thompson
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Trastuzumab acts in part through the adaptive immune system. Previous studies showed that enrichment of immune-related gene expression was associated with improved outcomes in HER2-positive (HER2+) breast cancer. However, the role of the imm
Externí odkaz:
https://doaj.org/article/c541e25cb1954a448e8d1d99ad81395d
Autor:
Saranya Chumsri, MD, Pooja P. Advani, MD, Tanmayi S. Pai, MD, Zhuo Li, MS, Ashita Mummareddy, Marites Acampora, APRN, Gina A. Reynolds, APRN, Natasha Wylie, APRN, Ashton W. Boyle, Yanyan Lou, MD, PhD, Kabir Mody, MD, Alvaro Moreno-Aspitia, MD, Melanie D. Swift, MD, MPH, Abinash Virk, MD, Adil E. Bharucha, MD, Christopher P. Marquez, MD, Tushar C. Patel, MD, Gregory J. Gores, MD, Keith L. Knutson, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 2, Pp 120-125 (2022)
Objective: To evaluate the magnitude of humoral response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in patients with cancer receiving active therapies. Patients and Methods: Patients 18 years or olde
Externí odkaz:
https://doaj.org/article/c346308a1a534e438fccc0f0a7479d5d
Autor:
Christopher Schiller, Sebastian Schmidtlein, Coline Boonman, Alvaro Moreno-Martínez, Teja Kattenborn
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Plant functional traits (‘traits’) are essential for assessing biodiversity and ecosystem processes, but cumbersome to measure. To facilitate trait measurements, we test if traits can be predicted through visible morphological features b
Externí odkaz:
https://doaj.org/article/107cbdaa3c7241659a83173551fcdcc3
Autor:
Logan M. Piening, David J. Lillyman, Fei San Lee, Alvaro Moreno Lozano, Jeremy R. Miles, Rebecca A. Wachs
Publikováno v:
JOR Spine, Vol 5, Iss 1, Pp n/a-n/a (2022)
Abstract Background Chronic low back pain (LBP) is a leading cause of disability, but treatments for LBP are limited. Degeneration of the intervertebral disc due to loss of neuroinhibitory sulfated glycosaminoglycans (sGAGs) allows nerves from dorsal
Externí odkaz:
https://doaj.org/article/0afad23070c64b1c95662e5dd34e832c
Autor:
Kurt A. Jaeckle, Jesse G. Dixon, Stephen Keith Anderson, Alvaro Moreno‐Aspitia, Gerardo Colon‐Otero, Kathy Hebenstreit, Tejal A. Patel, Samarth L. Reddy, Edith A. Perez
Publikováno v:
Cancer Medicine, Vol 9, Iss 21, Pp 7935-7942 (2020)
Abstract Background There are few treatment options for patients with leptomeningeal metastases (LM). Methods We report a case series of patients with breast cancer and LM treated with intra‐CSF topotecan (TOPO). Outcome was assessed by clinical ex
Externí odkaz:
https://doaj.org/article/084679dd348a4b969ff1555cfe063527
Autor:
Umair Majeed, Tudor Puiu, Jason Sluzevich, Gina Reynolds, Marites Acampora, Alvaro Moreno-Aspitia, Katherine J. Bodiford, Pooja Advani
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Alpelisib is a PIK3a inhibitor approved for the treatment of metastatic ER+ breast cancer in combination with fulvestrant. Although rash is a common side effect of this medication, we present the first case of drug reaction with eosinophilia and syst
Externí odkaz:
https://doaj.org/article/e8c1359fb89447618c412fdd3e63f7c0